3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Dermatologic
1
Conditions
Melanoma
50
Carcinoma, Non-Small-Cell Lung
39
Carcinoma, Renal Cell
29
Carcinoma, Hepatocellular
18
Neoplasm Metastasis
16
Neoplasms
15
Colorectal Neoplasms
15
Stomach Neoplasms
13
Lung Neoplasms
13
Adenocarcinoma Of Esophagus
11
Squamous Cell Carcinoma of Head and Neck
10
Carcinoma, Transitional Cell
8
Brain Neoplasms
8
Hodgkin Disease
7
Clear-cell metastatic renal cell carcinoma
7
Skin Neoplasms
6
Sarcoma
6
Esophageal Neoplasms
6
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Kidney Neoplasms
5
Carcinoma, Merkel Cell
5
Uveal Melanoma
4
Uterine Cervical Neoplasms
4
Urinary Bladder Neoplasms
4
Recurrence
4
Neuroendocrine Tumors
4
Nasopharyngeal Carcinoma
4
Glioma
4
Interventions
cemiplimab
1
Nivolumab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Cutaneous Squamous Cell Carcinoma (CSCC)
×
Nivolumab
×
Clear all
NCT06823479
2025-05-29
MATISSE 2
The Netherlands Cancer Institute
Phase 2
Recruiting
41 enrolled